Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC
Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC
Breastfeeding after breast cancer is safe
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC
Status of anti BCMA therapy in myeloma
Positive data for the use of radioligand therapy in first-line neuroendocrine cancers
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
Durable responses in aRCC, how do we optimise treatment?
Perspectives on advance care planning for advanced cancer in the Philippines
Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC
Preview: World Cancer Congress 2024
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients